Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Bayer has entered into a global agreement with Orion Corporation, a pharmaceutical company based in Espoo, Finland, for the development and commercialization of the compound ODM-201, an investigational novel oral androgen receptor inhibitor....

AbbVie Inc. has opened the company's newly expanded manufacturing facility in Sligo, Ireland. The expansion provides increased manufacturing capacity for the company's existing product portfolio as well as new therapies within the company's...

As part of a strategy to increase its position in pain care, Teva Pharmaceutical Industries Ltd. has agreed to acquire Labrys Biologics, Inc., a privately held development-stage biotechnology company focused on treatments for chronic migraines and...

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals International GmbH, report that the European Commission has granted marketing authorization for Entyvio (vedolizumab), a gut-selective humanized...

Eli Lilly and Company will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. This website, which houses data from several clinical trial sponsors, was created in support of ongoing...

Sanofi and its subsidiary Genzyme report that FDA has accepted for review the company's resubmission of its supplemental biologics license application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of...

Teva Pharmaceutical Industries Ltd. has announced a new organizational structure and related executive positions, effective July 1, 2014. The company will consist of two commercial business units: Global Specialty Medicines (GSM), which...

Novartis has named Bruno Strigini as president of Novartis Oncology, effective June 1, 2014. He joins Novartis from Merck & Co where he most recently served as president for Europe/Canada, a region comprising 37 countries with over 10,000...

The biopharmaceutical company Array BioPharma has formed a collaboration agreement with Biogen Idec  for the discovery and development of inhibitors targeting a kinase for treating autoimmune disorders.  Under the terms of the...